Journal of Rheumatic Diseases

Cited by CrossRef (15)

  1. Y. H. Lee, G. G. Song. Anifrolumab for the treatment of active systemic lupus erythematosus: a meta-analysis of randomized controlled trials. Z Rheumatol 2021;80:988
    https://doi.org/10.1007/s00393-020-00928-7
  2. Yoon‐Kyoung Sung, Young Ho Lee. Comparative effectiveness and safety of non‐tumour necrosis factor biologics and Janus kinase inhibitors in patients with active rheumatoid arthritis showing insufficient response to tumour necrosis factor inhibitors: A Bayesian network meta‐analysis of randomized controlled trials. J Clin Pharm Ther 2021;46:984
    https://doi.org/10.1111/jcpt.13380
  3. Young Ho Lee. Correspondence on ‘Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study‘. Annals of the Rheumatic Diseases 2022;81:e228
    https://doi.org/10.1136/annrheumdis-2020-218856
  4. Young Ho Lee, Gwan Gyu Song. Relative efficacy and safety of Janus kinase inhibitors for the treatment of active psoriatic arthritis: a network meta-analysis. Z Rheumatol 2023;82:408
    https://doi.org/10.1007/s00393-021-01119-8
  5. Young Ho Lee, Gwan Gyu Song. Mendelian Randomization Research on the Relationship Between Rheumatoid Arthritis and Systemic Lupus Erythematosus and the Risk of Autistic Spectrum Disorder. J Rheum Dis 2022;29:46
    https://doi.org/10.4078/jrd.2022.29.1.46
  6. G. G. Song, Y. H. Lee. Comparative efficacy and safety of mycophenolate mofetil versus cyclophosphamide in patients with active antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of randomized trials. Z Rheumatol 2021;80:425
    https://doi.org/10.1007/s00393-020-00803-5
  7. Young Ho Lee, Gwan Gyu Song. Comparative efficacy and safety of infliximab and its biosimilars in patients with rheumatoid arthritis presenting an insufficient response to methotrexate. Z Rheumatol 2023;82:114
    https://doi.org/10.1007/s00393-021-01040-0
  8. S.-C. Bae, Y. H. Lee. Causal association between periodontitis and risk of rheumatoid arthritis and systemic lupus erythematosus: a Mendelian randomization. Z Rheumatol 2020;79:929
    https://doi.org/10.1007/s00393-019-00742-w
  9. Young Ho Lee, Gwan Gyu Song. Comparison of the efficacy and safety of tofacitinib and peficitinib in patients with active rheumatoid arthritis: A Bayesian network meta‐analysis of randomized controlled trials. Int J of Rheum Dis 2020;23:868
    https://doi.org/10.1111/1756-185X.13854
  10. Young Ho Lee, Gwan Gyu Song. A network meta-analysis of randomized controlled trials comparing the effectiveness and safety of voclosporin or tacrolimus plus mycophenolate mofetil as induction treatment for lupus nephritis. Z Rheumatol 2023;82:580
    https://doi.org/10.1007/s00393-021-01087-z
  11. Young Ho Lee, Gwan Gyu Song. Comparative efficacy and safety of adalimumab biosimilars and adalimumab in patients with rheumatoid arthritis presenting an insufficient response to methotrexate: a network meta-analysis. Z Rheumatol 2023;82:64
    https://doi.org/10.1007/s00393-021-01013-3
  12. Young Ho Lee, Gwan Gyu Song. Meta-analysis of associations between interleukin-10 polymorphisms and susceptibility to Behcet’s disease. Immunol Res 2019;67:424
    https://doi.org/10.1007/s12026-019-09102-x
  13. Y. H. Lee, G. G. Song. Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in active rheumatoid arthritis refractory to biologic disease-modifying antirheumatic drugs. Z Rheumatol 2021;80:379
    https://doi.org/10.1007/s00393-020-00796-1
  14. So Hye Nam, Minju Kim, Ye-Jee Kim, Soo Min Ahn, Seockchan Hong, Chang-Keun Lee, Bin Yoo, Ji-Seon Oh, Yong-Gil Kim. Risk of New-Onset Diabetes Mellitus Associated with Antirheumatic Drugs in Patients with Rheumatoid Arthritis: A Nationwide Population Study. JCM 2022;11:2109
    https://doi.org/10.3390/jcm11082109
  15. Y.-K. Sung, Y. H. Lee. Comparative study of the efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib versus methotrexate for disease-modifying antirheumatic drug-naïve patients with rheumatoid arthritis. Z Rheumatol 2021;80:889
    https://doi.org/10.1007/s00393-020-00889-x